The Foundation Welcomes Two Distinguished Leaders to Its Board
The Foundation is pleased to announce the appointment of two exceptional individuals to its Board of Directors: Dr. Susan Harvey, MD, and Shaun O’Neil. Their expertise and leadership will be instrumental in advancing the Foundation's mission to raise awareness of the early signs and symptoms of esophageal cancer among young adults.
The John Michael Pierce Foundation is committed to tackling the increasing incidence of esophageal cancer in young adults. This often-overlooked disease frequently goes undetected until it reaches an advanced stage, thereby limiting the effectiveness of treatment. By educating young adults and their families about its early signs and symptoms, the Foundation aims to enhance early detection and improve treatment outcomes.
Dr. Susan Harvey, MD, joins the board with over 34 years of distinguished experience as an anatomic and clinical pathology specialist. Her extensive background in the medical field and her commitment to cancer research and prevention make her a valuable asset to the Foundation's efforts to educate the public and promote early diagnosis.
“I am honored and excited to join the John Michael Pierce Foundation,” said Susan Harvey. “As a pathologist I am responsible for diagnosing esophageal cancer and directing further ancillary tests that aid in treatment. Early diagnosis can only occur when patients seek care for their symptoms. I look forward to working with fellow board members to expand community knowledge of esophageal disease.”
Shaun O'Neil brings a wealth of experience from his role as President and Chief Operating Officer at Lucid Diagnostics, a cancer prevention medical diagnostics company. Lucid Diagnostics is focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer.
"Joining the John Michael Pierce Foundation's Board of Directors is a tremendous honor and responsibility," said Shaun O'Neil. "At Lucid, we're dedicated to eradicating esophageal cancer through early detection, a mission that aligns perfectly with the Foundation's goals. I'm excited to contribute my expertise and advocate for increased awareness of this preventable disease, ultimately helping to save lives through early detection and intervention."
"We are thrilled to welcome Dr. Susan Harvey and Shaun O’Neil to our Board of Directors," said Michelle Jenkins, Communications Director, of the John Michael Pierce Foundation. "Their combined experience and passion for advancing cancer awareness will be invaluable as we continue to fight for early detection of esophageal cancer in young adults."
The John Michael Pierce Foundation remains steadfast in its mission to educate and empower young adults about this critical health issue. With the addition of Dr. Harvey and Mr. O’Neil to the board, the Foundation is poised to expand its reach and impact more lives through awareness campaigns and educational programs.
For more information, please contact:
Michelle Jenkins
jmpfoundation.org
michelle@jmpfoundation.org
About the John Michael Pierce Foundation:
Founded in 2022, the John Michael Pierce Foundation is dedicated to raising awareness of esophageal cancer among young adults. Focusing on early detection and education, the Foundation works tirelessly to improve outcomes for those at risk.
⸻